Chemokine receptor binding polypeptides
US8591896B2 · kind B2 · utility
4Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2011 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | Nov 7, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to polypeptides directed against or specifically binding to chemokine receptor CXCR2 and in particular to polypeptides capable of modulating signal transduction from CXCR2. The invention also relates to nucleic acids, vectors and host cells capable of expressing the polypeptides of the invention, pharmaceutical compositions comprising the polypeptides and uses of said polypeptides and compositions for treatment of diseases involving aberrant functioning of CXCR2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.